These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2892219)

  • 21. Biological abnormalities in late-life depression.
    Alexopoulos GS
    J Geriatr Psychiatry; 1989; 22(1):25-34. PubMed ID: 2575097
    [No Abstract]   [Full Text] [Related]  

  • 22. Compartmentation of synaptic vesicles in autonomic neurons: morphological correlates of neurotransmitter pools in monoaminergic synapses; the vesicles as dual quantal elements in transmitter storage and release.
    Pellegrino de Iraldi A
    Adv Biochem Psychopharmacol; 1980; 25():255-68. PubMed ID: 6108683
    [No Abstract]   [Full Text] [Related]  

  • 23. Nutrition and transmitter amines in rat brain.
    Nutr Rev; 1977 Oct; 35(10):283-5. PubMed ID: 21365
    [No Abstract]   [Full Text] [Related]  

  • 24. Regional distribution of biogenic amines, amino acids and cholinergic markers in the CNS of the C57BL/6 strain.
    Van Dam D; Marescau B; Cremers T; Mulder J; Engelborghs S; De Deyn PP
    Amino Acids; 2005 Jun; 28(4):377-87. PubMed ID: 15889219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines.
    Spalletta G; Bossù P; Ciaramella A; Bria P; Caltagirone C; Robinson RG
    Mol Psychiatry; 2006 Nov; 11(11):984-91. PubMed ID: 16894392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on brain biogenic amines in methanolic extract of Cuscuta reflexa Roxb. and Corchorus olitorius Linn. seed treated mice.
    Gupta M; Mazumder UK; Pal D; Bhattacharya S; Chakrabarty S
    Acta Pol Pharm; 2003; 60(3):207-10. PubMed ID: 14556490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Depression in rheumatic diseases or somatic symptoms in depression].
    Carrière B
    Fortschr Med; 1981 Aug; 99(31-32):1226-30. PubMed ID: 6115801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoamine neurotransmitters in invertebrates and vertebrates: an examination of the diverse enzymatic pathways utilized to synthesize and inactivate biogenic amines.
    Sloley BD; Juorio AV
    Int Rev Neurobiol; 1995; 38():253-303. PubMed ID: 8537202
    [No Abstract]   [Full Text] [Related]  

  • 29. The GABA hypothesis of depression and antidepressant drug action.
    Bartholini G; Lloyd KG; Scatton B; Zivkovic B; Morselli PL
    Psychopharmacol Bull; 1985; 21(3):385-8. PubMed ID: 2994153
    [No Abstract]   [Full Text] [Related]  

  • 30. [Parkinson disease].
    Lauschke HP; Thieme F
    Z Arztl Fortbild (Jena); 1981 Aug; 75(15):681-5. PubMed ID: 6125059
    [No Abstract]   [Full Text] [Related]  

  • 31. Brain neurotransmitters in pyridoxine deficiency [proceedings].
    Dakshinamurti K
    Biochem Soc Trans; 1978; 6(1):119-20. PubMed ID: 25209
    [No Abstract]   [Full Text] [Related]  

  • 32. A risk factor strategy for investigating affective illness.
    Nurnberger JI; Jimerson DC; Bunney WE
    Biol Psychiatry; 1983 Aug; 18(8):903-9. PubMed ID: 6137250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is urinary MHPG a real predictor of drug response in primary depression?
    Cazzulo CL; Sacchetti E; Allaria E; Motta A; Conte G; Gasperini M; Smeraldi E
    Adv Biochem Psychopharmacol; 1982; 32():237-47. PubMed ID: 7090894
    [No Abstract]   [Full Text] [Related]  

  • 34. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
    Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of polyamine and biogenic amine systems in brains and hearts of neonatal rats given dexamethasone: role of biochemical alterations in cellular maturation for producing deficits in ontogeny of neurotransmitter levels, uptake, storage and turnover.
    Slotkin TA; Barnes G; Lau C; Seidler FJ; Trepanier P; Weigel SJ; Whitmore WL
    J Pharmacol Exp Ther; 1982 Jun; 221(3):686-93. PubMed ID: 6123585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics of the major psychoses.
    Gershon ES
    Res Publ Assoc Res Nerv Ment Dis; 1983; 60():121-44. PubMed ID: 6130584
    [No Abstract]   [Full Text] [Related]  

  • 37. 5-HT receptor regulation of neurotransmitter release.
    Fink KB; Göthert M
    Pharmacol Rev; 2007 Dec; 59(4):360-417. PubMed ID: 18160701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recovery from depression. Psychobiologic criteria of recovery].
    Poirier MF
    Encephale; 1993 Aug; 19 Spec No 3():451-8. PubMed ID: 7905407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain.
    Burchett SA; Hicks TP
    Prog Neurobiol; 2006 Aug; 79(5-6):223-46. PubMed ID: 16962229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The psychobiology of depressive disorders: from pathophysiology to predisposition.
    Depue RA; Evans R
    Prog Exp Pers Res; 1981; 10():1-114. PubMed ID: 6119738
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.